Presently PerClot from Starch Medical is sold internationally at a gross margin of 55%.
Per SA CRY can now produce PerClot in Georgia. Using PerClot produced by CRY, per SA, the gross margin is above 80%. If this is the case, why isn't CRY producing their own PerClot for sale into the international market? Afterall, CRY paid $1 million for the manufacturing license. My understanding is that the PerClot CRY intends to use for FDA clinical trial has already been manufactured in Georgia.
So again, why isn't CRY selling the above 80% margin PerClot instead of their selling the low margin stuff?